KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Acquisitions & Divestments (2016 - 2025)

Charles River Laboratories International has reported Change in Acquisitions & Divestments over the past 17 years, most recently at $3.5 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $3.5 million for Q4 2025, up 56.29% from a year ago — trailing twelve months through Dec 2025 was $9.1 million (down 78.17% YoY), and the annual figure for FY2025 was $9.1 million, down 78.17%.
  • Change in Acquisitions & Divestments for Q4 2025 was $3.5 million at Charles River Laboratories International, down from $3.5 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for CRL hit a ceiling of $27.1 million in Q3 2024 and a floor of $205000.0 in Q1 2022.
  • Median Change in Acquisitions & Divestments over the past 5 years was $2.1 million (2023), compared with a mean of $3.8 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: crashed 89.77% in 2021 and later surged 2584.26% in 2024.
  • Charles River Laboratories International's Change in Acquisitions & Divestments stood at $572000.0 in 2021, then skyrocketed by 152.62% to $1.4 million in 2022, then surged by 87.82% to $2.7 million in 2023, then dropped by 18.31% to $2.2 million in 2024, then skyrocketed by 56.29% to $3.5 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $504000.0 (Q2 2025) per Business Quant data.